Pārskats
Akcijas cenas izmaiņa
24h
Šī brīža
Min
1
Max
1.06
Rekomendācijas | Pirkt |
|---|---|
Prognoze 12 mēnešiem | +273.83% upside |
BioNano Genomics Inc Grafiks
Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.
Saistītās ziņas
2026. g. 31. jūl. 23:56 UTC
Citigroup maintained its Buy rating on Welltower and raised its price target to $275. Shares are modestly higher in after-market trading.
Lasīt
2026. g. 31. jūl. 23:56 UTC
Citigroup maintained its Buy rating on Neurocrine Biosciences and raised its price target to $249. Shares are higher in after-market trading.
Lasīt
2026. g. 31. jūl. 23:51 UTC
Meta Platforms Inc shares are lower in after-market hours, pressured by broader market weakness and concerns over rising AI spending following a disappointing earnings report.
Lasīt
2026. g. 31. jūl. 23:46 UTC
3M shares declined in after-market trading amid concerns over insider selling by EVP Kevin H. Rhodes, who sold $1.3 million worth of stock.
Lasīt
2026. g. 31. jūl. 23:41 UTC
Goldman Sachs shares declined in after-market trading amid broader market turmoil and hedge fund degrossing linked to losses on leveraged AI investments.
Lasīt
2026. g. 31. jūl. 23:41 UTC
JPMorgan Chase & Co. shares are lower in after-market trading following a note highlighting ongoing market rotation and challenges from rising long-term Treasury yields.
Lasīt
2026. g. 31. jūl. 23:36 UTC
Carvana shares declined in after-market trading following Citigroup's price target cut to $90, amid broader market weakness from Apple's disappointing guidance.
Lasīt
2026. g. 31. jūl. 23:36 UTC
DoorDash Inc shares are lower in after-market trading amid concerns over order demand and rising fuel prices ahead of its upcoming Q2 earnings report.
Lasīt
2026. g. 31. jūl. 23:36 UTC
Warner Bros Discovery shares are lower in after-market trading amid concerns over job losses tied to Paramount's $81 billion acquisition and its extended offer deadlines.
Lasīt
2026. g. 31. jūl. 23:36 UTC
Bloom Energy Corp shares are lower in after-market trading amid a class action lawsuit alleging securities fraud related to its reliance on Chinese scandium.
Lasīt
2026. g. 31. jūl. 23:32 UTC
Recursion Pharmaceuticals Inc shares are lower in after-market hours, reflecting broader market trends amid mixed performance among major tech stocks and upcoming economic data.
Lasīt
2026. g. 31. jūl. 23:31 UTC
KKR & Co Inc reported record Q2 revenue of $6.31 billion, yet shares are trading lower in after-market hours following earlier volatility.
Lasīt
2026. g. 31. jūl. 23:26 UTC
Norwegian Cruise Line shares are lower in after-market hours following Citigroup's price target cut to $22 amid ongoing valuation concerns.
Lasīt
2026. g. 31. jūl. 23:26 UTC
NOW Inc shares are higher after market hours, reflecting positive sentiment in the trading companies sector and ongoing demand for energy products.
Lasīt
2026. g. 31. jūl. 23:26 UTC
Pomerantz LLP has filed a class action lawsuit against Verra Mobility Corp for securities fraud, contributing to lower after-market trading for the company.
Lasīt
2026. g. 31. jūl. 23:26 UTC
Roblox Corp's stock is lower in after-market hours following UBS's price target cut to $45 and a class action lawsuit announcement by Pomerantz LLP.
Lasīt
2026. g. 31. jūl. 23:16 UTC
KBR Inc. reported second-quarter revenue of $1.98 billion and reaffirmed full-year guidance, but shares are trading lower in after-market hours.
Lasīt
2026. g. 31. jūl. 23:16 UTC
Tractor Supply Co reported second-quarter revenue of $4.54 billion, missing expectations. Shares are trading lower in after-market hours following the earnings release.
Lasīt
2026. g. 31. jūl. 23:16 UTC
PBF Energy shares are lower in after-market hours following Citigroup's Neutral rating and price target increase to $74. The stock remains above its 20-day moving average.
Lasīt
2026. g. 31. jūl. 23:16 UTC
Huntington Ingalls Industries shares rise in after-market trading following strong Q2 results, with sales of $3.42 billion and a non-GAAP profit of $5.27 per share.
Lasīt
2026. g. 31. jūl. 23:16 UTC
Shares of GE Healthcare Technologies are lower in after-market trading following UBS's Neutral rating and a price target increase to $73.
Lasīt
2026. g. 31. jūl. 23:16 UTC
Gilead Sciences shares are higher in after-market trading amid market fluctuations. Accessibility challenges for lenacapavir in Latin America may impact potential sales.
Lasīt
2026. g. 31. jūl. 23:16 UTC
Alnylam Pharmaceuticals reported Q2 2026 net product revenue of $1.2 billion, driven by strong AMVUTTRA uptake. Shares rose slightly in after-market trading.
Lasīt
2026. g. 31. jūl. 23:11 UTC
Lockheed Martin secured a $107.29 million Navy contract for VH-92A rotor blades, with shares trading higher in after-market hours.
Lasīt
2026. g. 31. jūl. 23:06 UTC
Hawaiian Electric Industries has signed a 30-year power purchase agreement, with shares trading higher in after-market hours.
Lasīt
2026. g. 31. jūl. 23:06 UTC
General Electric Co shares are lower in after-market trading, despite recent analyst upgrades and reaffirmed buy ratings for GE Aerospace.
Lasīt
2026. g. 31. jūl. 23:06 UTC
Regeneron Pharmaceuticals shares declined in after-market hours following a class action lawsuit alleging securities fraud related to its Phase III study modifications.
Lasīt
2026. g. 31. jūl. 23:06 UTC
Permian Resources Corp shares are trading higher in after-market hours following recognition as a top investment choice by Yahoo Finance, citing strong financial performance.
Lasīt
2026. g. 31. jūl. 23:06 UTC
NVIDIA shares are lower in after-market trading despite strong fiscal first-quarter results, with revenues of $81.6 billion and record data center sales.
Lasīt
2026. g. 31. jūl. 23:06 UTC
Coinbase Global reported a record share of global crypto trading volume but also a significant net loss. Shares are roughly flat in after-market trading.
Lasīt
Salīdzinājums
Cenas izmaiņa
BioNano Genomics Inc Prognoze
Cenas mērķis
By TipRanks
Prognoze 12 mēnešiem
Vidējais 4 USD 273.83%
Augstākais 4 USD
Zemākais 4 USD
Pamatojoties uz 1 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi BioNano Genomics Inc — pēdējo 3 mēnešu laikā.
Vērtējuma vienprātība
By TipRanks
Pirkt
1 ratings
1
Pirkt
0
Turēt
0
Pārdot
Pamatojoties uz 1 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam BioNano Genomics Inc — pēdējo 3 mēnešu laikā.
Finanšu rādītāji
$